Tramadol – A Global Issue

Tramadol – A Global Issue
Global consumption of the opioid Tramadol, a drug that in some parts of the world is unregulated, increased 186 percent between 2000 and 2012, reports the International Narcotics Control Board. In the United States, the synthetic opioid analgesic received government approval in 2010. By 2014, the Drug Enforcement Administration had placed it on the controlled substances list with a Schedule IV classification. Tramadol was developed by German scientists in the early ’60s and goes by the trade name Ultram. The drug, which many believed held non-addictive properties, is prescribed for moderate to severe pain in adults. The DEA’s Schedule IV classification suggests a “low potential for abuse” but that is simply not true, and people are getting addicted in large numbers. Unlike other opiates, the low potential for abuse is only when the drug is injected. Tramadol is an oral medication though, and The Wall Street Journal writes that recent research...
Rate this blog entry:
Continue reading
796 Hits